Ensysce Biosciences (ENSCW) Invested Capital (2020 - 2025)
Historic Invested Capital for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to $1.2 million.
- Ensysce Biosciences' Invested Capital fell 8258.07% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 8258.07%. This contributed to the annual value of $3.7 million for FY2024, which is 66941.65% up from last year.
- Per Ensysce Biosciences' latest filing, its Invested Capital stood at $1.2 million for Q3 2025, which was down 8258.07% from $3.4 million recorded in Q2 2025.
- In the past 5 years, Ensysce Biosciences' Invested Capital registered a high of $6.9 million during Q3 2024, and its lowest value of -$8.2 million during Q4 2021.
- Moreover, its 5-year median value for Invested Capital was $1.3 million (2022), whereas its average is $554740.4.
- As far as peak fluctuations go, Ensysce Biosciences' Invested Capital crashed by 135915.43% in 2022, and later surged by 66941.65% in 2024.
- Quarter analysis of 5 years shows Ensysce Biosciences' Invested Capital stood at -$8.2 million in 2021, then surged by 50.61% to -$4.0 million in 2022, then soared by 83.84% to -$651267.0 in 2023, then surged by 669.42% to $3.7 million in 2024, then tumbled by 67.55% to $1.2 million in 2025.
- Its Invested Capital stands at $1.2 million for Q3 2025, versus $3.4 million for Q2 2025 and $3.0 million for Q1 2025.